Medicine, poison, and mystic potion: a personal perspective on paracetamol Louis Roche lecture, Stockholm, 2009

References

• Persson H. European Association of Poisons Centres and Clinical Toxicologists – a perspective over four decades, 1964–2004. EAPCCT 2004. http://www.eapact.org. Accessed 10 March 2009.
   Google Scholar
• Bertolini A, Ferrari A, Ottani A, Guerzoni S, Tacchi R, Leone S. Paracetamol: new vistas of an old drug. CNS Drug Rev 2006; 12:250–275.
   PubMedGoogle Scholar
• Brodie BB, Axelrod J. The fate of acetanilide in man. J Pharmacol Exp Ther 1948; 94:29–38.
   PubMed Web of Science ®Google Scholar
• Davidson DGD, Eastham WN. Acute liver necrosis following overdose of paracetamol. BMJ 1966; 2:497–499.
   PubMed Web of Science ®Google Scholar
• Thomson JS, Prescott LF. Liver damage and impaired glucose tolerance after paracetamol overdosage. BMJ 1966; 2:506–507.
   PubMed Web of Science ®Google Scholar
• Prescott LF, Roscoe P, Wright N, Brown S. Plasma paracetamol half-life and hepatic necrosis in patients with paracetamol overdosage. Lancet 1971; 1:519–522.
   PubMed Web of Science ®Google Scholar
• Prescott LF. Prevention of hepatic necrosis following paracetamol over-dosage. Health Bull 1978; 36:204–212.
   PubMedGoogle Scholar
• Mitchell J, Jollow D, Potter W, Gilette J, Brodie BB. Acetaminophen-induced hepatic necrosis. Protective role of glutathione. J Pharmacol Exp Ther 1973; 187:211–217.
   PubMed Web of Science ®Google Scholar
• Prescott LF, Illingworth RN, Critchley JA, Stewart MJ, Adam RD, Proudfoot AT. Intravenous N-acetylcystine: the treatment of choice for paracetamol poisoning. BMJ 1979; 2:1097–1100.
   PubMed Web of Science ®Google Scholar
• Vale J, Meredith T, Goulding R. Treatment of acetaminophen poisoning. The use of oral methionine. Arch Intern Med 1981; 141:394–396.
   PubMed Web of Science ®Google Scholar
• Douglas A, Hamlyn A, James O. Controlled trial of cysteamine in treatment of acute paracetamol (acetaminophen) poisoning. Lancet 1976; 1:111–115.
   PubMed Web of Science ®Google Scholar
• Rumack BH, Matthew H. Acetaminophen poisoning and toxicity. Pediatrics 1975; 55:871–876.
   PubMed Web of Science ®Google Scholar
• Rumack BH. Acetaminophen hepatotoxicity: the first 35 years. J Toxicol Clin Toxicol 2002; 40:3–20.
   PubMed Web of Science ®Google Scholar
• Walton N, Mann T, Shaw K. Anaphylactoid reaction to N-acetylcysteine. Lancet 1979; 2:1298.
   PubMed Web of Science ®Google Scholar
• Mant T, Tempowski J, Volans G, Talbot J. Adverse reactions to acetylcysteine and effects of overdose. BMJ 1984; 289:217–219.
   PubMed Web of Science ®Google Scholar
• Bateman DN, Woodhouse K, Rawlins M. Adverse reactions to N‐acetylcysteine. Hum Toxicol. 1984; 3:393–398.
   PubMedGoogle Scholar
• British Medical Association and Royal Pharmaceutical Society of great Britain. British National Formulary. 58th ed. UK: BMJ and RPSGB, 2009.
   Google Scholar
• Hawton K, Townsend E, Deeks J, Appleby L, Gunnell D, Bennewith O, Cooper J. Effects of legislation restricting pack sizes of paracetamol and salicylate on self poisoning in the United Kingdom: before and after study. BMJ 2001; 322:1203–1207.
   PubMed Web of Science ®Google Scholar
• Bateman DN, Gorman D, Bain M, Inglis J, House F, Murphy D. Legislation restricting paracetamol sales and patterns of self-harm and death from paracetamol-containing preparations in Scotland. Br J Clin Pharmacol 2006; 62:573–581.
   PubMed Web of Science ®Google Scholar
• Morgan O, Griffiths C, Majeed A. Interrupted time-series analysis of regulations to reduce paracetamol (acetaminophen) poisoning. PLoS Med 2007; 4:e105.
   PubMed Web of Science ®Google Scholar
• Bateman DN. Limiting paracetamol pack size: has it worked in the UK? Clin Toxicol (Phila) 2009; 47:536–541.
   PubMed Web of Science ®Google Scholar
• Waring WS, Stephen AF, Robinson OD, Dow MA, Pettie JM. Lower incidence of anaphylactoid reactions to N-acetylcysteine in patients with high acetaminophen concentrations after overdose. Clin Toxicol 2008; 46:496–500.
   PubMed Web of Science ®Google Scholar
• Schmidt L, Dalhoff K. Risk factors in the development of adverse reactions to N-acetylcysteine in patients with paracetamol poisoning. Br J Clin Pharmacol 2001; 51:87–91.
   PubMed Web of Science ®Google Scholar
• Pakravan N, Waring WS, Sharma S, Ludlam C, Megson I, Bateman DN. Risk Factors and mechanisms of anaphylactoid reactions to acetylcysteine in acetaminophen overdose. Clin Toxicol (Phila) 2008; 46:697–702.
   PubMed Web of Science ®Google Scholar
• Sandllands E, Bateman D. Adverse reactions associated with acetylcysteine. Clin Toxicol (Phila) 2009; 47:81–88.
   PubMed Web of Science ®Google Scholar
• Yang R, Miki K, He X, Killeen M, Fink M. Prolonged treatment with N-acetylcysteine delays liver recovery from acetaminophen hepatotoxicity. Crit Care 2009; 13:R55.
   PubMed Web of Science ®Google Scholar
• Beer C, Pakravan K, Hudson M, Smith LT, Simpson K, Bateman DN, Thomas SHL. Liver unit admission following paracetamol overdose with concentrations below current UK treatment thresholds. Q J Med 2007; 100:93–96.
   Google Scholar
• Prescott LF, Proudfoot AT, Cregeen R. Paracetamol-induced acute kidney failure in the absence of fulminant liver damage. BMJ 1982; 284:421–422.
   PubMed Web of Science ®Google Scholar
• O’Grady JG, Alexander GJ, Hayllar KM, Williams R. Early indicators of prognosis in fulminant hepatic failure. Gastroenterology 1989; 97:439–445.
   PubMed Web of Science ®Google Scholar
• Pakravan N, Simpson K, Waring WS, Bates CM, Bateman DN. Renal injury at first presentation as a predictor for poor outcome in severe paracetamol poisoning referred to a liver transplant unit. Eur J Clin Pharmacol 2008; 65:163–168.
   PubMed Web of Science ®Google Scholar
• Jones A, Harvey J, Vale J. Hypophosphataemia and phosphaturia in paracetamol poisoning. Lancet 1989; 334:608–609.
   Google Scholar
• Pakravan N, Goddard J, Bateman DN. Effect of acute paracetamol overdose on changes in serum and urine electrolytes. Br J Clin Pharmacol 2007; 64:824–832.
   PubMed Web of Science ®Google Scholar
• Hinson JA, Roberts DW, James LP. Mechanisms of acetaminophen-induced liver necrosis. Handb Exp Pharmacol 2010; 196:369–405.
   PubMedGoogle Scholar
• Poltorak A, He X, Smirnova I, Liu MY, Van Huffel C, Du X, Birdwell D, Alejos E, Silva M, Galanos C, Freudenberg M, Ricciardi-Castagnoli P, Layton B, Beutler B. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 1998; 282:2085–2088.
   PubMed Web of Science ®Google Scholar
• Kono H, Rock KL. How dying cells alert the immune system to danger. Nat Rev Immunol 2008; 8:279–289.
   PubMed Web of Science ®Google Scholar
• Zhang-Xu L, Derick H, Basuki G, Neil K. Neutrophil depletion protects against murine acetaminophen hepatotoxicity. Hepatology 2006; 43:1220–1230.
   PubMed Web of Science ®Google Scholar
• Chen CJ, Kono H, Golenbock D, Reed G, Akira S, Rock KL. Identification of a key pathway required for the sterile inflammatory response triggered by dying cells. Nat Med 2007; 13:851–856.
   PubMed Web of Science ®Google Scholar
• Imaeda AB, Watanabe A, Sohail MA, Mahmood S, Mohamadnejad M, Sutterwala FS, Flavell RA, Mehal WZ. Acetaminophen-induced hepatotoxicity in mice is dependent on Tlr9 and the Nalp3 inflammasome. J Clin Invest 2009; 119:305–314.
   PubMed Web of Science ®Google Scholar
• Scaffidi P, Misteli T, Bianchi ME. Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature 2002; 418:191–195.
   PubMed Web of Science ®Google Scholar
• Shi Y, Evans JE, Rock KL. Molecular identification of a danger signal that alerts the immune system to dying cells. Nature 2003; 425:516–521.
   PubMed Web of Science ®Google Scholar